Stock Screener App

Frei - Play StoreApp Store

Installieren Installieren

Dow:

Nasdaq:

S&P 500:

ILMN

$235.9918.64%-54.07

Nachbörslich: 236.54+0.55 +0.23%

Illumina Inc (ILMN)

Date: O: H: L: C: Vol:

Illumina Inc Aktie (ILMN) Neueste Nachrichten

ILMN Q3 Earnings Call Highlights Higher Guidance and Clinical Growth - Zacks Investment Research

Why is Illumina stock tumbling today? - Investing.com

Illumina, Inc. (ILMN) Stock Forecasts - Yahoo Finance

Illumina (ILMN) Reports Q3 Earnings: What Key Metrics Have to Say - Zacks Investment Research

Illumina Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView

Illumina, Inc. (ILMN) Seasonal returns chart - Yahoo Finance Singapore

Transcript : Illumina, Inc., Q3 2026 Earnings Call, Oct 29, 2026 - www.marketscreener.com

Illumina Q3 Earnings Call Highlights - Yahoo Finance

Illumina, Inc. (ILMN) Seasonal Returns Chart - Yahoo Finance - Yahoo! Finance Canada

Illumina, Inc. (ILMN) Seasonal returns chart - Yahoo Finance UK

Illumina Inc Reports Q3 2026 Earnings: GAAP EPS of $1.43 Surpasses Estimates, Revenue Hits $1.13 Billion - GuruFocus

Illumina Q3 2026 Earnings Call Transcript - Benzinga

Illumina falls despite boosting full-year profit, revenue guidance - Seeking Alpha

Illumina, Inc. Provides Earnings Guidance for the Fiscal Year 2026 - www.marketscreener.com

Illumina (ILMN) Q3 Earnings Beat Estimates - Yahoo Finance

ILLUMINA INC. R (ILU.DE) Q3 FY2026 earnings call transcript - Yahoo Finance

Earnings Flash (ILMN) Illumina, Inc. Reports Q3 Revenue $1.13B, vs. FactSet Est of $1.15B - www.marketscreener.com

Illumina (NASDAQ:ILMN) reports sales below analyst estimates in Q3 2026 earnings, stock drops 16% - Yahoo Finance

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026 - Illumina

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026 - Yahoo Finance

Thailand Next Generation Sequencing (NGS) Market Size, Share, Trends, and Forecast - 2026 to 2036 | Precision Medicine Drives 12.7% CAGR and a $305.21 Million Opportunity - GlobeNewswire Inc.

Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE? - The Motley Fool

Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year - TradingView

VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? - The Motley Fool

Illumina downgraded by Stephens with a new price target - Quantisnow

Should Illumina Stock Holders Look At Thermo Fisher Instead? - Trefis

Here’s How Much You Would Have Made Owning Illumina Stock In The Last 20 Years - Benzinga

Illumina, Inc. Estimates – NASDAQ:ILMN - TradingView

Illumina stock may move 9.3% on earnings release - Investing.com

Illumina: NovaSeq X And Consumables Sustain Momentum (NASDAQ:ILMN) - Seeking Alpha

Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research

Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance - TradingView

Illumina's Stock Has Run Ahead Of Its Q3 Step-Down, Raising The Stakes On Clinical Demand - Finviz

Illumina Jumps 5.4% Amid Sector-Wide Rally - AlphaStreet

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Illumina’s (ILMN) Strong Quarterly Beats on Revenue and Earnings Drive Share Gains - Yahoo Finance

Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery - Illumina

Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery - PR Newswire

Illumina, Inc. (ILMN) Launches Early-Access AI Genomics Tools - TradingView

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Zacks Investment Research

Single Cell Sequencing Market Forecast to 2035: Services, Technologies, End-users, Applications, and Regions | 15% CAGR Drives Drug Discovery and Precision Medicine Growth - GlobeNewswire Inc.

Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research

In Brief This Week: Illumina, Interpace, Ocugen, Roots, Elicera, Verily, Quantum-Si, More - GenomeWeb

Illumina, Inc. (ILMN) Options Chain - Yahoo! Finance Canada

Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch

TD Cowen lifts target for Illumina stock to USD 270.00 - ad-hoc-news.de

Saudi Arabia Non-Invasive Prenatal Testing Market 2026-2034: Executive Report | NGS Adoption and Healthcare Investment Drive 13.35% CAGR Toward US$162.16 Million - GlobeNewswire Inc.

$100 Invested In Illumina 15 Years Ago Would Be Worth This Much Today - Benzinga

Ähnlich wie ILMN

MTD$1,674.812.55%

IDXX$551.214.30%

DGX$251.820.43%

IQV$267.332.81%

WAT$462.723.61%